7. Although arsenic is known to be a poison, it also has some beneficial medicinal uses. In one study of the use of arsenic to treat acute promyelocytic leukemia (APL), a rare type if blood cancer, APL patients were given an arsenic compound as part of their treatment. Of those receiving arsenic, 32% were in remission and showed no signs of leukemia in subsequent examination. It is known that 18% of APL patients go into remission after conventional treatment. Suppose that the study had included 100 randomly selected patients. Is there sufficient evidence to conclude that the proportion in remission after the arsenic treatment is greater than 0.18, the remission proportion for conventional treatment? Test the relevant hypothesis at the 0.01 significance level. Be sure to show all steps for the hypothesis test.
7. Although arsenic is known to be a poison, it also has some beneficial medicinal uses....
Identify the scientific premise, main hypothesis addressed by
the paper and the research question of the paper
Also, what is the main results and the implication of
results
IMPORTANCE Clinical outcomes for glioblastoma remain poor. Treatment with immune checkpoint blockade has shown benefits in many cancer types. To our knowledge, data from a randomized phase 3 clinical trial evaluating a programmed death-1 (PD-1) inhibitor therapy for glioblastoma have not been reported. OBJECTIVE To determine whether single-agent PD-1 blockade with nivolumab...
what resear questions can be asked and why on the topic; Why
Doctors Still Offer Treatments That May Not Help
Why Doctors Still Offer Treatments That May Not Help idence-based medicine has made progress since doctors' infamous bloodletting of George Washington, but less than you might think New York Times By Austin Frakt . Aug. 26, 2019 X Image LEECHES A leech basin and other bloodletting instruments, taken by Meriwether Lewis and William Clark on their expedition to the West...
please provide a summary with intext citaion for this article: T HE HEART AND ESTROGEN/ progestin Replacement Study (HERS) was a randomized, blinded, placebo-controlled trial of the effect of 0.625 mg of conjugated estrogens plus 2.5 mg of medroxyprogesterone acetate daily on coronary heart disease (CHD) event risk among 2763 postmenopausal women with documented CHD.1 Overall, during 4.1 years of follow-up, there were no significant differences between the hormone and placebo groups in the primary outcome of CHD events (nonfatal...
Please read the article bellow and discuss the shift in the
company's approach to genetic analysis. Please also discuss what
you think about personal genomic companies' approaches to research.
Feel free to compare 23andMe's polices on research with another
company's. Did you think the FDA was right in prohibiting 23andMe
from providing health information?
These are some sample talking points to get you thinking about
the ethics of genetic research in the context of Big Data. You
don't have to...